In initial studies using CLL samples from 4 patients, (including an ATM dysfunctional and a del11q case) proliferating CLL cells cultured on the CD40L-expressing cells for 72 hr were exposed to talazoparib (0-10,000 nM) (Method 1). This evidence concerns the gene ATM and B-cell chronic lymphocytic leukemia.